Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / NVS - AstraZeneca considering bid for Mereo BioPharma - Report


NVS - AstraZeneca considering bid for Mereo BioPharma - Report

The ADRs of Mereo BioPharma (MREO) jumped ~15% in the pre-market Monday after The Times reported that Anglo Dutch pharma giant AstraZeneca (NASDAQ:AZN) is considering a bid for the U.K.-based biotech. AstraZeneca (AZN) already has a partnership with Mereo (MREO). According to the report, one of the other partners of the company including Novartis (NVS), OncXerna and Ultragenyx (RARE) is likely to rival AstraZeneca (AZN) in its bidding.

For further details see:

AstraZeneca considering bid for Mereo BioPharma – Report
Stock Information

Company Name: Novartis AG
Stock Symbol: NVS
Market: NYSE
Website: novartis.com

Menu

NVS NVS Quote NVS Short NVS News NVS Articles NVS Message Board
Get NVS Alerts

News, Short Squeeze, Breakout and More Instantly...